Absci gained on animal testing phaseout news, but the change has limited near-term impact on its investment case. Read why ...

Absci management will webcast a corresponding ... we are going to take a look at where Advanced Micro Devices, Inc. (NASDAQ:AMD) stands against other AI stocks. As per a CNBC report, in 2025 ...

In a report released today, Scott Schoenhaus from KeyBanc maintained a Buy rating on AbSci (ABSI – Research Report), with a price target of $9.00. Discover outperforming stocks and invest ...

Next-generation AMD EPYC CPU, codenamed “Venice,” is the first HPC product to be brought up on TSMC’s next-generation N2 node — SANTA CLARA, Calif., April 14, 2025 (GLOBE NEWSWIRE ...

The U.S. Food and Drug Administration (FDA) announced its plans to end the mandatory animal testing of new drugs, a move that sent AI-enabled biotech companies such as Recursion Pharmaceuticals ...

AMD has just announced that its next-gen EPYC processor codenamed "Venice" is the first HPC product in the industry to be taped out and brought up on TSMC's advanced 2nm (N2) process technology ...

AstraZeneca has agreed a deal worth up to $247 million with US generative artificial intelligence (GenAI) company Absci that will focus on the discovery of a new antibody-based drug for cancer.

Do you agree with the decision to reduce the stipend for beneficiaries of the Mukhya Mantri Majhi Ladki Bahin Yojana? No, it negatively impacts the beneficiaries. Yes, it's necessary to ensure ...